Inflammation and Colon Cancer

Terzić, Janoš, Grivennikov, Sergei, Karin, Eliad, Karin, Michael·2010·Gastroenterology
DOI 10.1053/j.gastro.2010.01.058

Cites (247)

Items 201–243 of 243

  1. Intestinal Mucosal Inflammation Leads to Systemic Genotoxicity in Mice
    Aya M. Westbrook, Bo Wei, Jonathan G. Braun, Robert H. Schiestl · 2009 · Cancer Research
  2. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation
    Thomas Clavel, Dirk Haller · 2007 · Inflammatory Bowel Diseases
  3. Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase Inhibition in the Gastrointestinal Tract: A Trip From Peptic Ulcer to Colon Cancer
    Ángel Lanas · 2009 · The American Journal of the Medical Sciences
  4. Cancer Occurrence
    Ahmedin Jemal, Elizabeth Ward, Michael J. Thun · 2008 · Methods in molecular biology
  5. Microsatelite GT polymorphism in the toll‐like receptor 2 is associated with colorectal cancer
    Tihana Boraska Jelavić, Marin Barišić, Irena Drmić Hofman, Vesna Boraska Perica, Eduard Vrdoljak, Marijana Peruzović, Izet Hozo, Željko Puljiz, Janoš Terzić · 2006 · Clinical Genetics
  6. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc ( Min/+ ) colon epithelial cell line
    Jenifer I. Fenton, Stephen David Hursting, Susan N. Perkins, Norman G. Hord · 2006 · Carcinogenesis
  7. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
    Sanda Šturlan, Georg Oberhuber, Britta G. Beinhauer, Brigitte Tichy, Sonja Kappel, Jacob Wang, Michael A. Rogy · 2001 · Carcinogenesis
  8. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies
    Imke Atreya, Markus Friedrich Neurath · 2008 · Expert Review of Anticancer Therapy
  9. Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis
    Yunfei Zhou, Song Li, Yi Peter Hu, Jing Wang, Jennie Hauser, Alexis N. Conway, Michelle A. Vinci, Lisa E. Humphrey, Elizabeth Zborowska, James K. V. Willson et al. · 2006 · Cancer Research
  10. The role of signal transducers and activators of transcription in colon cancer
    Lidija Klampfer · 2007 · Frontiers in bioscience
  11. Intracellular Signals and Events Activated by Cytokines of the Tumor Necrosis Factor Superfamily: From Simple Paradigms to Complex Mechanisms
    Sergei I. Grivennikov, Dmitry V. Kuprash, Zheng‐gang Liu, Sergei A. Nedospasov · 2006 · International review of cytology
  12. Role of toll-like receptors in tissue repair and tumorigenesis
    Seth Rakoff-Nahoum, Ruslan M. Medzhitov · 2008 · Biochemistry (Moscow)
  13. Nuclear translocation of beta-catenin in hereditary and carcinogen- induced intestinal adenomas
    H Sheng · 1998 · Carcinogenesis
  14. Transforming Growth Factor-β Suppresses Nonmetastatic Colon Cancer through Smad4 and Adaptor Protein ELF at an Early Stage of Tumorigenesis
    Yi Tang, Varalakshmi Katuri, Radhika Srinivasan, Franz Fogt, Robert S. Redman, Girish Anand, Anan H. Said, Thomas Fishbein, MICHAEL A. ZASLOFF, E. Premkumar Reddy et al. · 2005 · Cancer Research
  15. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis
    Christer G. B. Peterson, Per Sangfelt, M. Wagner, T. Hansson, Helene Lettesjö, Marie Carlson · 2007 · Scandinavian Journal of Clinical and Laboratory Investigation
  16. Prostaglandins and epithelial response to injury
    William F. Stenson · 2007 · Current Opinion in Gastroenterology
  17. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.
    Maciej Chichlowski, Julie M. Sharp, Deborah A. Vanderford, Matthew H. Myles, Laura P. Hale · 2008 · PubMed Central
  18. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: Mouse models
    Andrey Kruglov, Anna A. Kuchmiy, Sergei I. Grivennikov, Alexei V. Tumanov, Dmitry V. Kuprash, Sergei A. Nedospasov · 2008 · Cytokine & Growth Factor Reviews
  19. Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
    Robert A. Edwards, Mavee Witherspoon, Kehui Wang, Kambiz Afrasiabi, Trang Thuy Pham, Lutz Birnbaumer, Steven M. Lipkin · 2009 · Cancer Research
  20. COX-2 and colon cancer
    Makoto Mark Taketo · 1998 · Inflammation Research
  21. Microbial–host interactions specifically control the glycosylation pattern in intestinal mouse mucosa
    Miguel Freitas, Lars-Göran Axelsson, Chantal Cayuela, Tore Midtvedt, Germain Trugnan · 2002 · Histochemistry and Cell Biology
  22. PRODUCTION OF CYTOKINES BY MONOCYTES, EPITHELIAL AND ENDOTHELIAL CELLS ACTIVATED BY STREPTOCOCCUS BOVIS
    Stéphan Ellmerich, Nabil Djouder, Marie Scholler, Jean-Paul Klein · 2000 · Cytokine
  23. Inhibition of Transforming Growth Factor-β Signaling in Human Cancer: Targeting a Tumor Suppressor Network as a Therapeutic Strategy
    Swati Biswas, Tracy L. Criswell, Shizhen Emily Wang, Carlos L. Arteaga · 2006 · Clinical Cancer Research
  24. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
    Stefan Fichtner‐Feigl, Warren Strober, Edward Kenneth Geissler, HJ Schlitt · 2008 · Mucosal Immunology
  25. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.
    Andrew J Wilson, Anna Velcich, Diego Arango, Amy R. Kurland, Shailesh M. Shenoy, Rossanna C. Pezo, Jeffrey M. Levsky, Robert H. Singer, Leonard H. Augenlicht · 2002 · PubMed
  26. Phosphorylation and Regulation of -Catenin by Casein Kinase I
    Chie Sakanaka · 2002 · The Journal of Biochemistry
  27. Functional Cross-talk between β-Catenin and NFκB Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin
    Shahid Umar, Shubhashish Sarkar, Yu Wang, Pomila Singh · 2009 · Journal of Biological Chemistry
  28. Tumors with microsatellite instability: many mutations, targets and paradoxes
    Manuel Perucho · 2003 · Oncogene
  29. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors
    Carl C. Schimanski, Peter R. Galle, Markus Hermann Moehler · 2008 · World Journal of Gastroenterology
  30. Cytokines in Colitis-Associated Cancer: Potential Drug Targets?
    Maximilian J. Waldner, Markus Friedrich Neurath, Markus Markus · 2008 · Inflammation & Allergy - Drug Targets
  31. Dual alterations in casein kinase I-ε and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia
    Shahid Umar, Yu Wang, Andrew P. Morris, Joseph H. Sellin · 2006 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  32. Genome-Wide Association Studies Herald a New Era of Rapid Discoveries in Inflammatory Bowel Disease Research
    Richard H. Duerr · 2007 · Gastroenterology
  33. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma
    R. Zhang, A. Ma, Stefan J. Urbanski, Donna‐Marie McCafferty · 2006 · Carcinogenesis
  34. Trefoil factor-3 expression in human colon cancer liver metastasis
    Mark W. Babyatsky, Jing Lin, Xianyang Yio, Anli Chen, Jieyu Zhang, Yan Zheng, Christina Twyman-Saint Victor, Xiuliang Bao, Myron Schwartz, Swan N. Thung et al. · 2008 · Clinical & Experimental Metastasis
  35. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas
    Takanori Kitamura, Kyoko Biyajima, Masahiro Aoki, Masanobu Oshima, Makoto Mark Taketo · 2008 · Laboratory Investigation
  36. Mob-1, a Ras target gene, is overexpressed in colorectal cancer
    Rong Zhang, Hong Zhang, Weimin Zhu, Arthur B. Pardee, RJ Coffey, Peng Liang · 1997 · Oncogene
  37. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1α-hydroxyvitamin D5
    Genoveva Murillo, Rajendra G. Mehta · 2005 · The Journal of Steroid Biochemistry and Molecular Biology
  38. Modeling the function of tumor necrosis factor in immune pathophysiology.
    George A. Kollias · 2004 · PubMed
  39. A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis
    Hiroki Makita, Michihiro Mutoh, Takayuki Maruyama, K. Yonemoto, A. Kobayashi, H. Fujitsuka, Makoto Toida, T. Shibata, S. Miyamoto, Yumiko Yasui et al. · 2006 · Carcinogenesis
  40. Gene‐specific oxidative DNA damage in Helicobacter pylori –infected human gastric mucosa
    Jinhee Choi, Sunhee Yoon, Ja‐Eun Kim, Kwang‐Ho Rhee, Hee‐sang Youn, Myung-Hee Chung · 2002 · International Journal of Cancer
  41. Effects of intestinal bacteria on the development of colonic neoplasm II. Changes in the immunological environment
    Hisanaga Horie, K Kanazawa, Eiji Kobayashi, Masaki Okada, Akio Fujimura, S Vamagiwa, Toru Abo · 1999 · European Journal of Cancer Prevention
  42. Rationale for combining biotherapy in the treatment of advanced colon cancer.
    Deirdre Jill Cohen, Howard S. Höchster · 2008 · PubMed
  43. Intestinal inflammation is coordinated by the metalloprotease ADAM17
    Stefan Rose‐John, Athena Chalaris, Nina Adam, Christian Sina, Philip C Rosenstiel, Karina Reiß, Joanna Cichy, Jürgen Scheller · 2009 · Cytokine